Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TN/Memphis
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Memphis, TN

Studies commonly pay $75 to $4,500 per completed study

580 clinical trials are currently recruiting participants within 30 miles of Memphis. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

580studies recruiting
1+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Memphis right now

Top 25 of 580 recruiting studies, sorted by proximity — each links to its official registry page

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Charles Retina Institute — Germantown, Tennessee (9.0 mi) · Sponsor: Genentech, Inc.

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Memphis, Tennessee (5.5 mi) · Sponsor: Sameek Roychowdhury

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought
Stern Cardiovascular — Southaven, Mississippi (8.7 mi) · Sponsor: Duke University

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Memphis, Tennessee (5.5 mi) · Sponsor: Daiichi Sankyo

ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

Dravet Syndrome Phase 1, Phase 2 Interventional 32 participants sought
Le Bonheur Children's Hospital — Memphis, Tennessee (5.5 mi) · Sponsor: Ionis Pharmaceuticals, Inc.

Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)

Low-Risk, Early Stage Breast Cancer N/A Interventional 400 participants sought
The West Clinic, PC dba West Cancer Center — Germantown, Tennessee (9.0 mi) · Sponsor: IceCure Medical Ltd.

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Solid Tumors, Hematologic Malignancies Phase 3 Interventional 3,500 participants sought
West Cancer Center and Research Institute ( Site 0055) — Germantown, Tennessee (9.0 mi) · Sponsor: Merck Sharp & Dohme LLC

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Baptist Memorial Hospital and Cancer Center-Memphis — Memphis, Tennessee (5.5 mi) · Sponsor: SWOG Cancer Research Network

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Papillary Thyroid Cancer, Pediatric Cancer N/A Observational 32 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi) · Sponsor: Children's Hospital of Philadelphia

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Acute Myeloid Leukemia (AML) Phase 3 Interventional 1,300 participants sought
Baptist Clinical Research Institute — Memphis, Tennessee (5.5 mi) · Sponsor: Kura Oncology, Inc.

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer Phase 3 Interventional 1,000 participants sought
The West Clinic, PLLC dba West Cancer Center — Germantown, Tennessee (9.0 mi) · Sponsor: Pfizer

A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma

Neuroblastoma Recurrent Phase 2 Interventional 54 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi) · Sponsor: St. Jude Children's Research Hospital

Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer: A Randomized Clinical Trial

Childhood Cancer Survivor, Chronic Pain N/A Interventional 116 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi) · Sponsor: St. Jude Children's Research Hospital

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis N/A Observational 400 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi) · Sponsor: Arkansas Children's Hospital Research Institute

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma Phase 2 Interventional 90 participants sought
NACHO Consortium — Memphis, Tennessee (5.5 mi) · Sponsor: Carl Allen

A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Amyloid Plaque, Beta-Amyloid Phase 1, Phase 2 Interventional 304 participants sought
Neurology Clinical, P.C. — Cordova, Tennessee (11.2 mi) · Sponsor: AC Immune SA

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Phase 3 Interventional 356 participants sought
Baptist Memorial Hospital and Cancer Center-Memphis — Memphis, Tennessee (5.5 mi) · Sponsor: NRG Oncology

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

Vulvovaginal Candidiasis (VVC), Yeast Vaginitis N/A Interventional 55 participants sought
Aviati Health — Memphis, Tennessee (5.5 mi) · Sponsor: Coologics, Inc

Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas

Sarcoma, Childhood Osteosarcoma Phase 1 Interventional 42 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi) · Sponsor: St. Jude Children's Research Hospital

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

Carcinoma, Renal Cell Phase 3 Interventional 758 participants sought
The West Clinic, P.C. ( Site 0115) — Germantown, Tennessee (9.0 mi) · Sponsor: Merck Sharp & Dohme LLC

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

Failed or Difficult Intubation, Sequela, Intubation; Difficult N/A Observational 150,000 participants sought
Le Bonheur Children's Hospital — Memphis, Tennessee (5.5 mi) · Sponsor: Children's Hospital of Philadelphia
Actively enrolling

Studies you may be able to join near Memphis

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Memphis

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Baptist Clinical Research Institute

6025 Walnut Grove Rd #500, Memphis, TN 38120
(901) 226-1821

Clinical trials in Memphis: what's recruiting

The Memphis area currently has 580 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Memphis, the most active research areas are:

  • Cancer & Oncology16 studies
  • Heart & Vascular2 studies
  • Brain & Mental Health2 studies
  • Lungs & Breathing1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Memphis, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Memphis

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Memphis participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Memphis?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Memphis, TN?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Memphis?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Memphis.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Memphis typically complete one or two studies per year.

Paid clinical trials near Memphis

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of TN

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts